As of January 23, 2025, NanoViricides (NNVC) has a market cap of $17.073 million USD. According to our data, NanoViricides is ranked No.8668 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $17.07 M |
-16.78%
|
Dec 31, 2024 | $20.52 M |
40.20%
|
Dec 29, 2023 | $14.63 M |
-8.11%
|
Dec 30, 2022 | $15.93 M |
-70.16%
|
Dec 31, 2021 | $53.37 M |
29.62%
|
Dec 31, 2020 | $41.18 M |
14.34%
|
Dec 31, 2019 | $36.01 M |
-37.25%
|
Dec 31, 2018 | $57.39 M |
-77.27%
|
Dec 29, 2017 | $0.25 B |
-17.76%
|
Dec 30, 2016 | $0.31 B |
-9.32%
|
Dec 31, 2015 | $0.34 B |
-56.62%
|
Dec 31, 2014 | $0.78 B |
-43.33%
|
Dec 31, 2013 | $1.38 B |
191.79%
|
Dec 31, 2012 | $0.47 B |
-24.19%
|
Dec 30, 2011 | $0.62 B |
-57.82%
|
Dec 31, 2010 | $1.48 B |
72.94%
|
Dec 31, 2009 | $0.85 B |
4.94%
|
Dec 31, 2008 | $0.81 B |
107.69%
|
Dec 31, 2007 | $0.39 B |
-47.30%
|
Dec 29, 2006 | $0.74 B |
-16.85%
|
Dec 30, 2005 | $0.89 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
Vir Biotechnology
VIR
|
$1.45 B |
0.000 M
|
USA
|
Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
Inovio Pharmaceuticals
INO
|
$81.23 M |
0.000 M
|
USA
|
Arcturus Therapeutics
ARCT
|
$0.45 B |
0.000 M
|
USA
|
Vaxart
VXRT
|
$0.19 B |
-0.000 M
|
USA
|
Dynavax Technologies
DVAX
|
$1.63 B |
-0.000 M
|
USA
|
Altimmune
ALT
|
$0.49 B |
0.000 M
|
USA
|
Tonix Pharmaceuticals
TNXP
|
$59.62 M |
0.000 M
|
USA
|
Atea Pharmaceuticals
AVIR
|
$0.26 B |
0.000 M
|
USA
|
Ocugen
OCGN
|
$0.22 B |
0.000 M
|
USA
|
Market Cap | = | NNVC Stock Price | * | NNVC Shares Outstanding |
= | $1.19 | * | 14.35 M | |
= | $17.07 M |